自動系統(00771.HK)因轉換可換股債券而發行約2197.8萬股
格隆匯11月20日丨自動系統(00771.HK)公告,於2019年11月20日, 公司接獲Triple Wise轉換通知,內容有關按經調整換股價每股0.91港元(較於本公告日期收市價每股1.02港元溢價約12.09%)行使本金額為2000萬港元可換股債券所附帶轉換權。
因該轉換,本公司於2019年11月20日向Triple Wise配發及發行2197.8萬股換股股份,佔經配發及發行換股股份擴大後已發行股份數目約2.66%。換股股份於所有方面與於配發日期所有現有股份及彼此間享有同等地位。緊隨該轉換後,尚未行使可換股債券本金總額將降至2.3億港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.